© 2019 NeuroOne Medical Technologies CorporationTerms of UsePrivacy Policy
NeuroOne Products Are Under Development • NeuroOne Medical Cortical Electrodes Are Pending 510(k) Clearance

Investor Overview

Company Profile

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. We are currently focused on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity.

 

Corporate Presentation
Deck-Cover-2018.png

Investment Relations

Dave Rosa

President and CEO

contact@neurooneinc.com

 

Corporate Securities Counsel

Honigman LLP

650 Trade Centre Way

Suite 200

Kalamazoo, MI 49002

(269) 337-7702

Auditor

BDO USA

800 Nicollet Mall Suite 600

Minneapolis, MN 55405

(612) 367-3000

 

Transfer Agent

Action Stock Transfer

(801) 274-1088

action@actionstocktransfer.com

 

Board of Directors

Paul Buckman
Chairman
Suraj Kalia
Director
Dave Rosa
President and CEO

Governance Documents

Frequently Asked Questions

When was NeuroOne incorporated?
We were originally incorporated in the state of Nevada on August 20, 2009 as Original Source Entertainment, Inc. We changed our name to NeuroOne Medical Technologies Corporation and reincorporated in Delaware before we entered into an agreement and plan of merger on July 20, 2017 to acquire NeuroOne, Inc., which was incorporated under the laws of the State of Delaware on October 7, 2016. The NeuroOne, Inc. predecessor entity, NeuroOne LLC, was formed on December 13, 2013 and operated as a limited liability company until it was merged with and into NeuroOne, Inc.

When is NeuroOne’s fiscal year end?
September 30th

Who are NeuroOne’s independent auditors?
BDO USA LLP

Who is NeuroOne’s outside legal counsel?
Honigman Miller Schwartz and Cohn LLP

Can I buy stock directly from NeuroOne?
No, you will need to contact a licensed stock broker or use an online trading account

How do I get my purchased shares?
Contact Action Stock Transfer by telephone at (801) 274-1088 or by email at action@actionstocktransfer.com

What is NeurOne’s CUSIP number?
64130M100

Who can I contact for general information about NeuroOne?
Email us at contact@neurooneinc.com

Where is NeuroOne located?
7599 Anagram Drive, Eden Prairie, MN 55344

SEC Filings

SIC: 3841 - SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
State location: MN | State of Inc.: DE | Fiscal Year End: 0930

Press Releases 

NeuroOne provides updates to the market through press releases and other media coverage.